P. A. von dem Borne

J. Falkenburg, A. Kruisselbrink, P. A. von dem Borne, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved diagnosis of viral encephalitis in adult and pediatric hematological patients using viral metagenomics

M. Feltkamp, J. Verschuuren, I. Sidorov, 2020, bioRxiv.

The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole‐resistance. A nationwide survey and rationale for the DB‐MSG 002 study protocol

B. Biemond, N. de Jonge, A. Bart, 2018, Mycoses.

Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity

J. Falkenburg, R. Willemze, M. Griffioen, 2008, Proceedings of the National Academy of Sciences.

High Mutation Frequency of the PIGA Gene in T Cells Results in Reconstitution of GPI Anchor−/CD52− T Cells That Can Give Early Immune Protection after Alemtuzumab-Based T Cell–Depleted Allogeneic Stem Cell Transplantation

H. Veelken, P. A. von dem Borne, I. Jedema, 2018, The Journal of Immunology.

Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing

J. Falkenburg, M. Heemskerk, R. Willemze, 2007, Haematologica.

Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.

J. Cornelissen, E. D. de Kort, B. Rijnders, 2019, The Journal of antimicrobial chemotherapy.

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.

J. Cornelissen, J. Boelens, A. Vonk, 2016, The Journal of antimicrobial chemotherapy.

Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome.

O. Dekkers, P. A. von dem Borne, M. D. de Boer, 2014, Medical mycology.

Effectivity of a strategy in elderly AML patients to reach allogeneic stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy.

J. Falkenburg, H. Veelken, P. A. von dem Borne, 2016, Leukemia research.

Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor

P. A. von dem Borne, B. Bouma, Linda M P Cox, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing.

E. Claas, P. A. von dem Borne, A. Kroes, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Surface Independent Factor XI Activation by Thrombin in the Presence of High Molecular Weight Kininogen

P. A. von dem Borne, J. Meijers, B. Bouma, 1994, Thrombosis and Haemostasis.

Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.

J. Falkenburg, J. Zwaginga, H. Veelken, 2020, Cytotherapy.

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

Marcelo A. Navarrete, J. Falkenburg, F. Claas, 2017, The Journal of clinical investigation.

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

P. A. von dem Borne, B. Bouma, J. Meijers, 2006, Journal of thrombosis and haemostasis : JTH.

The Effect of Graft-Versus-Host Disease on Skin Endothelial and Epithelial Cell Chimerism in Stem-Cell Transplant Recipients

P. A. von dem Borne, I. Bajema, J. Vossen, 2009, Transplantation.

Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance

J. van Paassen, P. A. von dem Borne, J. Koopmans, 2021, Medical mycology.

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

N. Kröger, S. Iacobelli, E. Tholouli, 2017, Haematologica.

Binding of amyloid β precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke

R. Roos, P. A. von dem Borne, J. Meijers, 1998, Journal of Neurology.

Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status

I. Yakoub-Agha, D. Blaise, M. Mohty, 2020, Bone Marrow Transplantation.

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, D. Blaise, 2017, Bone Marrow Transplantation.

Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients

J. D. de Soet, C. van Loveren, J. Raber-Durlacher, 2012, Supportive Care in Cancer.

Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.

P. Sonneveld, P. A. von dem Borne, M. Minnema, 2019, Blood advances.

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

P. A. von dem Borne, J. Meijers, B N Bouma, 1995, Blood.

Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients

H. Veelken, P. A. von dem Borne, W. Marijt, 2023, Annals of Hematology.

Competitive repopulation and allo-immunological pressure determine chimerism kinetics after T-cell depleted allogeneic stem cell transplantation and donor lymphocyte infusions.

H. Veelken, P. A. von dem Borne, L. D. de Wreede, 2022, Transplantation and cellular therapy.

Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft.

H. Veelken, P. A. von dem Borne, D. Moes, 2019, Transplant immunology.

Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.

F. Claas, B. van der Holt, P. A. von dem Borne, 2014, Transplant immunology.

Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft (‘Campath in the bag’)

R. Willemze, W. Fibbe, P. A. von dem Borne, 2009, Current opinion in oncology.

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 stud

U. Mellqvist, M. Dimopoulos, P. Sonneveld, 2020, The Lancet. Haematology.

Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study

E. Beckers, J. Zwaginga, J. G. van der Bom, 2020, Annals of Hematology.

Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients

H. Guchelaar, S. Böhringer, J. Swen, 2013, Pharmacogenetics and genomics.

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations

B. van der Holt, J. Calis, J. Cornelissen, 2019, Front. Immunol..

Fever, shock, and pancytopenia in a patient treated with alemtuzumab.

J. V. van Dissel, P. A. von dem Borne, M. Bauer, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

A. Lankester, P. A. von dem Borne, S. Kruithof, 2012, Journal of immunotherapy.

Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies

J. Bourhis, N. Ifrah, E. Gluckman, 2017, British journal of haematology.

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

P. Sonneveld, E. Vellenga, B. van der Holt, 2010, Blood.

Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome

D. Chitu, P. A. von dem Borne, M. Fiocco, 2023, BMC Infectious Diseases.

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

M. Kersten, P. Sonneveld, E. Vellenga, 2018, The Lancet. Haematology.

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors

C. Voorter, P. A. von dem Borne, G. Bos, 2020, Annals of Hematology.

A diagnostic difficulty: two cases of haemophagocytic syndrome in adults.

A. Fogteloo, J. E. Roeters van Lennep, C. Wijsman, 2009, The Netherlands journal of medicine.

Distribution and clinical determinants of time‐to‐positivity of blood cultures in patients with neutropenia

O. Dekkers, H. Veelken, L. Visser, 2018, European journal of haematology.

Effect of Heparin on the Activation of Factor XI by Fibrin-bound Thrombin

P. A. von dem Borne, J. Meijers, B. Bouma, 1996, Thrombosis and Haemostasis.

Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.

R. Willemze, P. A. von dem Borne, M. Vermeer, 2008, The Journal of investigative dermatology.

Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia

J. Zwaginga, M. Huisman, J. G. van der Bom, 2021, European journal of haematology.

Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab.

J. Falkenburg, G. Hale, W. Fibbe, 2006, Haematologica.

Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

B. Biemond, A. Bart, J. Doorduijn, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rhinovirus viremia in adult patients with high viral load in bronchoalveolar lavages.

E. Claas, J. D. de Vries, P. A. von dem Borne, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The Effect of Graft-Versus-Host Disease on Skin Endothelial and Epithelial Cell Chimerism in Stem-Cell Transplant Recipients

P. A. von dem Borne, I. Bajema, J. Vossen, 2009, Transplantation.

Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity.

A. Kruisselbrink, P. A. von dem Borne, I. Jedema, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.